PRRX2 and central nervous system cancer: All the qPCR (Fig. 5l), western blotting (Fig. 5m) and immunohistochemistry assays (Fig. 5n) confirmed PRRX2 expressed higher in glioma and GBM tissues than the NBT and even higher with increasing WHO grades, and the highest expression was found in GBM.